Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$306.88 - $380.0 $398,944 - $494,000
-1,300 Reduced 11.82%
9,700 $3.67 Million
Q2 2023

Aug 03, 2023

SELL
$346.15 - $392.09 $207,690 - $235,253
-600 Reduced 5.17%
11,000 $4.22 Million
Q1 2023

Apr 21, 2023

SELL
$323.56 - $373.36 $679,476 - $784,056
-2,100 Reduced 15.33%
11,600 $4.33 Million
Q4 2022

Feb 02, 2023

BUY
$248.67 - $334.17 $422,739 - $568,089
1,700 Added 14.17%
13,700 $4.53 Million
Q3 2022

Oct 17, 2022

BUY
$263.81 - $337.27 $342,953 - $438,451
1,300 Added 12.15%
12,000 $3.17 Million
Q2 2022

Aug 11, 2022

BUY
$301.4 - $428.42 $964,479 - $1.37 Million
3,200 Added 42.67%
10,700 $3.35 Million
Q1 2022

May 09, 2022

BUY
$379.46 - $424.54 $2.43 Million - $2.72 Million
6,400 Added 581.82%
7,500 $3.13 Million
Q4 2021

Feb 11, 2022

SELL
$373.53 - $434.12 $2.73 Million - $3.17 Million
-7,300 Reduced 86.9%
1,100 $461,000
Q3 2021

Nov 10, 2021

SELL
$396.76 - $455.92 $1.35 Million - $1.55 Million
-3,400 Reduced 28.81%
8,400 $3.47 Million
Q2 2021

Aug 12, 2021

BUY
$372.36 - $412.07 $1.38 Million - $1.52 Million
3,700 Added 45.68%
11,800 $4.68 Million
Q1 2021

May 11, 2021

SELL
$357.26 - $392.57 $71,452 - $78,514
-200 Reduced 2.41%
8,100 $3.11 Million
Q4 2020

Feb 09, 2021

BUY
$319.05 - $363.32 $127,620 - $145,328
400 Added 5.06%
8,300 $3.02 Million
Q3 2020

Oct 22, 2020

SELL
$280.08 - $347.78 $4.2 Million - $5.22 Million
-15,000 Reduced 65.5%
7,900 $2.66 Million
Q2 2020

Aug 11, 2020

BUY
$270.93 - $320.3 $894,069 - $1.06 Million
3,300 Added 16.84%
22,900 $6.5 Million
Q1 2020

May 04, 2020

BUY
$243.44 - $359.98 $4.77 Million - $7.06 Million
19,600 New
19,600 $5.4 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.